These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7596191)

  • 41. Comprehensive flow cytometry phenotype in acute leukemia at diagnosis and at relapse.
    Li X; Du W; Liu W; Li X; Li H; Huang SA
    APMIS; 2010 May; 118(5):353-9. PubMed ID: 20477810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML.
    Macedo A; Orfao A; Martínez A; Vidriales MB; Valverde B; López-Berges MC; San Miguel JF
    Br J Haematol; 1995 Feb; 89(2):338-41. PubMed ID: 7532985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry.
    Terstappen LW; Loken MR
    Anal Cell Pathol; 1990 Jul; 2(4):229-40. PubMed ID: 1703434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myeloid differentiation antigens identify leukemic cell subpopulations with different cell cycle characteristics.
    Campos L; Ffrench M; Guyotat D
    Leukemia; 1990 Jan; 4(1):60-2. PubMed ID: 1688640
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia.
    Coustan-Smith E; Behm FG; Hurwitz CA; Rivera GK; Campana D
    Leukemia; 1993 Jun; 7(6):853-8. PubMed ID: 7684798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication.
    Muñoz L; Aventín A; Villamor N; Juncà J; Acebedo G; Domingo A; Rozman M; Torres JP; Tormo M; Nomdedéu JF
    Haematologica; 2003 Jun; 88(6):637-45. PubMed ID: 12801839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
    Solary E; Casasnovas RO; Campos L; Béné MC; Faure G; Maingon P; Falkenrodt A; Lenormand B; Genetet N
    Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro infection of leukemic bone marrow with HTLV-I generates immortalized cell lines expressing T or myeloid cell phenotype.
    Giuliani A; Vernole P; D'Atri S; Del Poeta G; D'Onofrio C; Faraoni I; Greiner JW; Bonmassar E; Graziani G
    Leukemia; 1995 Dec; 9(12):2071-81. PubMed ID: 8609719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiparametric flow cytometry in detection of minimal residual disease in acute lymphoblastic leukemia of early B-cell phenotype.
    Mlcáková A; Babusíková O
    Neoplasma; 2003; 50(6):416-21. PubMed ID: 14689062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping.
    Gorczyca W
    Pol J Pathol; 2012 Mar; 63(1):8-17. PubMed ID: 22535601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
    Munker R; Andreeff M
    Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+).
    Raymakers R; Wittebol S; Pennings A; Linders E; Poddighe P; De Witte T
    Leukemia; 1995 Mar; 9(3):450-7. PubMed ID: 7533867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
    Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
    Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia.
    Lacombe F; Durrieu F; Briais A; Dumain P; Belloc F; Bascans E; Reiffers J; Boisseau MR; Bernard P
    Leukemia; 1997 Nov; 11(11):1878-86. PubMed ID: 9369421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of unusual immunophenotype combinations in acute myelogenous leukemia.
    Reading CL; Estey EH; Huh YO; Claxton DF; Sanchez G; Terstappen LW; O'Brien MC; Baron S; Deisseroth AB
    Blood; 1993 Jun; 81(11):3083-90. PubMed ID: 8499643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of immunophenotypic characteristics of blast cells in acute myeloid leukemia.
    Lanza F; Rigolin GM; Moretti S; Latorraca A; Castoldi G
    Leuk Lymphoma; 1994; 13 Suppl 1():81-5. PubMed ID: 7521238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease.
    Macedo A; San Miguel JF; Vidriales MB; López-Berges MC; García-Marcos MA; Gonzalez M; Landolfi C; Orfão A
    J Clin Pathol; 1996 Jan; 49(1):15-8. PubMed ID: 8666678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.